Company Filing History:
2 out of 1,290 
1 out of 1 
1 out of 832,912 Years Active: 2011-2016
Title: Eisei Noiri: Innovator in Prognosis Diagnosis Methods
Introduction
Eisei Noiri is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the areas of sepsis and malaria testing. With a total of 2 patents, his work has the potential to greatly enhance patient care and treatment outcomes.
Latest Patents
Noiri's latest patents include a prognosis diagnosis method and a prognosis diagnosis kit for sepsis or multiple organ failure. This innovative method allows for the simple and accurate diagnosis of a patient's prognosis suffering from sepsis or sepsis-related multiple organ failure. The process involves detecting a liver fatty acid-binding protein in urine using a specific antibody, followed by a comparison of detection values to determine prognosis. Additionally, he has developed a method, reagent, and kit for malaria testing, which facilitates the detection of malaria infection and its extent through the analysis of liver-type fatty acid binding protein in urine samples.
Career Highlights
Eisei Noiri has worked with esteemed institutions such as the University of Tokyo and Z Protein Laboratories, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Takeshi Sugaya and Yoshitsugu Matsumoto. Their collaborative efforts have further advanced the research and development of diagnostic methods.
Conclusion
Eisei Noiri's innovative work in prognosis diagnosis methods showcases his dedication to improving medical diagnostics. His contributions have the potential to significantly impact patient care and treatment strategies in critical medical conditions.